Biontech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
90.13UNCH (UNCH)
Volume
7,845
Close
90.13quote price arrow down-0.75 (-0.83%)
Volume
335,162
52 week range
85.21 - 125.83
Loading...
  • Open90.72
  • Day High90.99
  • Day Low89.38
  • Prev Close90.88
  • 52 Week High125.83
  • 52 Week High Date08/31/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24

Key Stats

  • Market Cap21.426B
  • Shares Out237.73M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change-14.6

KEY STATS

  • Open90.72
  • Day High90.99
  • Day Low89.38
  • Prev Close90.88
  • 52 Week High125.83
  • 52 Week High Date08/31/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24
  • Market Cap21.426B
  • Shares Out237.73M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change-14.6

RATIOS/PROFITABILITY

  • EPS (TTM)39.99
  • P/E (TTM)2.25
  • Fwd P/E (NTM)-37.77
  • EBITDA (TTM)-188.805M
  • ROE (TTM)0.56%
  • Revenue (TTM)2.935B
  • Gross Margin (TTM)79.38%
  • Net Margin (TTM)4.14%
  • Debt To Equity (MRQ)1.18%

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biontech SE

 

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting Ph.D.
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
GMAB
Genmab A/S
28.80-0.49-1.67%
ALNY
Alnylam Pharmaceuticals Inc
152.29-2.04-1.32%
NBIX
Neurocrine Biosciences Inc
139.02-4.17-2.91%
EXAS
Exact Sciences Corp
59.48-1.93-3.14%
ILMN
Illumina Inc
110.62-2.20-1.95%